Taishan Liu, Jiayun Hao, Huan Lei, Yanru Chen, Lin Liu, Liping Jia, Juan Gu, Huaping Kang, Jingjing Shi, Jing He, Yangbin Song, Yuqi Tang, Daidi Fan
{"title":"Recombinant collagen for the repair of skin wounds and photo-aging damage.","authors":"Taishan Liu, Jiayun Hao, Huan Lei, Yanru Chen, Lin Liu, Liping Jia, Juan Gu, Huaping Kang, Jingjing Shi, Jing He, Yangbin Song, Yuqi Tang, Daidi Fan","doi":"10.1093/rb/rbae108","DOIUrl":null,"url":null,"abstract":"<p><p>The skin, being the body's primary defense mechanism, is susceptible to various injuries such as epidermal wounds, natural aging, and ultraviolet-induced damage. As a result, there is growing interest in researching skin repair methods. Traditional animal-derived collagen, widely available on the market, poses risks due to its immunogenicity and potential for viral contamination. In contrast, recombinant collagen sourced from human genes offers a safer alternative. To investigate the potential of human recombinant collagen in skin repair, our research team applied two types, type I human collagen (Col I) and CF-1552(I), to two different skin injury models: a wound-healing model and a photo-aging model. Our findings indicate that both Col I and CF-1552(I) effectively enhance wound healing and repair skin damaged by ultraviolet exposure. Notably, CF-1552(I) showed effects comparable to Col I in promoting cell proliferation in the wound-healing model and increasing malondialdehyde content in the photo-aging model, suggesting that CF-1552(I) may offer greater potential for skin repair compared to the larger Col I molecule.</p>","PeriodicalId":20929,"journal":{"name":"Regenerative Biomaterials","volume":"11 ","pages":"rbae108"},"PeriodicalIF":5.6000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11422187/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regenerative Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1093/rb/rbae108","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
The skin, being the body's primary defense mechanism, is susceptible to various injuries such as epidermal wounds, natural aging, and ultraviolet-induced damage. As a result, there is growing interest in researching skin repair methods. Traditional animal-derived collagen, widely available on the market, poses risks due to its immunogenicity and potential for viral contamination. In contrast, recombinant collagen sourced from human genes offers a safer alternative. To investigate the potential of human recombinant collagen in skin repair, our research team applied two types, type I human collagen (Col I) and CF-1552(I), to two different skin injury models: a wound-healing model and a photo-aging model. Our findings indicate that both Col I and CF-1552(I) effectively enhance wound healing and repair skin damaged by ultraviolet exposure. Notably, CF-1552(I) showed effects comparable to Col I in promoting cell proliferation in the wound-healing model and increasing malondialdehyde content in the photo-aging model, suggesting that CF-1552(I) may offer greater potential for skin repair compared to the larger Col I molecule.
皮肤是人体的主要防御机制,很容易受到各种伤害,如表皮伤口、自然老化和紫外线引起的损伤。因此,人们对皮肤修复方法的研究兴趣与日俱增。传统的动物来源胶原蛋白在市场上广泛销售,但由于其免疫原性和潜在的病毒污染,存在一定风险。相比之下,源自人类基因的重组胶原蛋白提供了更安全的替代品。为了研究人类重组胶原蛋白在皮肤修复方面的潜力,我们的研究团队将 I 型人类胶原蛋白(Col I)和 CF-1552(I)两种类型应用于两种不同的皮肤损伤模型:伤口愈合模型和光老化模型。我们的研究结果表明,Col I 和 CF-1552(I)都能有效促进伤口愈合,修复因紫外线照射而受损的皮肤。值得注意的是,CF-1552(I)在促进伤口愈合模型中的细胞增殖和增加光老化模型中的丙二醛含量方面的效果与 Col I 相当,这表明与较大的 Col I 分子相比,CF-1552(I)可能具有更大的皮肤修复潜力。
期刊介绍:
Regenerative Biomaterials is an international, interdisciplinary, peer-reviewed journal publishing the latest advances in biomaterials and regenerative medicine. The journal provides a forum for the publication of original research papers, reviews, clinical case reports, and commentaries on the topics relevant to the development of advanced regenerative biomaterials concerning novel regenerative technologies and therapeutic approaches for the regeneration and repair of damaged tissues and organs. The interactions of biomaterials with cells and tissue, especially with stem cells, will be of particular focus.